Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMEM209 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SNAPC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIAT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PLPP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA1328 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00115 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT4P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAPN7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHF12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DBT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCM10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCAF17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM198 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM38B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PEX19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFP90 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on